This Phase 1 clinical trial is a double-blind, single-center, randomized, placebo- and
positive-controlled, parallel-group, 'nested crossover' trial with multiple oral dose
administration of pritelivir or matching placebo as well as a single oral administration of
moxifloxacin (positive control) and corresponding matching placebo in healthy male and female
subjects.
Phase:
Phase 1
Details
Lead Sponsor:
AiCuris Anti-infective Cures AG
Treatments:
Moxifloxacin Norgestimate, ethinyl estradiol drug combination Pritelivir